Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05238077 · ClinicalTrials.gov registry record · NA
Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
A NA study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05238077 is a NA study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 1 participants.
The verdict
NCT05238077, a NA study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
As part of this study, you may have a procedure called phototherapy which involves either VL-UVA or NB-UVB irradiation. NB-UVB phototherapy is not experimental in vitiligo, but use of VL-UVA1 phototherapy in vitiligo is. The purpose of this pilot study is to determine whether VL-UVA1 or NB-UVB phototherapy more efficiently induces repigmentation in patients with generalized vitiligo.
Interventions
- PROCEDURE Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-02-26 |
| Est. Completion | 2020-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05238077
The ClinicalTrials.gov registry entry for NCT05238077 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy is the first listed.
NCT05238077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05238077 about?
NCT05238077 is a clinical study titled "Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo". As part of this study, you may have a procedure called phototherapy which involves either VL-UVA or NB-UVB irradiation. NB-UVB phototherapy is not experimental in vitiligo, but use of VL-UVA1 phototherapy in vitiligo is. The purpose of this pilot study is to determine whether VL-UVA1 or NB-UVB phot...
What is the current status of trial NCT05238077?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-02-26. Estimated completion is 2020-06-02.
What interventions are being tested in trial NCT05238077?
The interventions under investigation include: Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy (PROCEDURE).
Who is sponsoring clinical trial NCT05238077?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.